Glucagon-like Peptide‐1 Agonists Reduce Cardiovascular Events in Cancer Patients on Immune Checkpoint Inhibitors

DOI: 10.1016/j.ejca.2024.115170 Publication Date: 2024-12-11T17:59:33Z